Marburg virus is a filamentous, single-stranded RNA virus belonging to the filovirus family, the same group that includes Ebola. It causes severe hemorrhagic fever with fatality rates that have ranged from roughly 24% to 90% across different outbreaks, depending on the viral strain and available medical care.1PubMed Central. Marburg virus disease: Emerging threat, pathogenesis, and global public health strategies Understanding how the virus is built, how it reaches and enters human cells, and what it does once inside helps explain both why it is so dangerous and where researchers are finding opportunities to stop it.
Discovery and Outbreak History
The first recognized Marburg virus outbreak occurred in 1967 in Germany and the former Yugoslavia, when laboratory workers handling tissues from imported African green monkeys fell ill with a mysterious hemorrhagic disease.2PubMed Central. Forty-five years of Marburg virus research The virus takes its name from the German city of Marburg, where the largest cluster of those initial cases occurred. Since then, outbreaks have surfaced repeatedly in sub-Saharan Africa, particularly in Uganda, the Democratic Republic of the Congo, Angola, and, most recently, Rwanda. The Angola outbreak in 2004–2005 was among the deadliest, with a case-fatality rate exceeding 80%. Differences in fatality rates across outbreaks reflect not just strain variation but also stark differences in how quickly cases are detected and how much supportive care is available.
Genome Organization
Marburg virus carries one of the largest genomes found among negative-sense RNA viruses, stretching about 19.1 kilobases in length.3PubMed. Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle “Negative-sense” means the RNA cannot be read directly by the cell’s protein-making machinery; the virus must first copy it into a mirror-image strand before any viral proteins can be produced. The genome encodes seven genes arranged in a fixed order, and those genes produce everything the virus needs: a nucleoprotein (NP) that wraps around the RNA, a surface glycoprotein (GP) that latches onto host cells, a matrix protein (VP40) that shapes the virus particle, accessory proteins (VP35, VP30, VP24) involved in replication and immune evasion, and a large polymerase (L) that copies the genome.3PubMed. Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle This gene layout closely resembles that of other members of the order Mononegavirales, which also includes the paramyxoviruses (like measles) and rhabdoviruses (like rabies).4PubMed Central. Filovirus replication and transcription
Virion Shape and the Matrix Layer
Under an electron microscope, Marburg virus particles look like long, twisted threads or shepherd’s crooks, a shape shared with Ebola. At the core of each particle sits a helical nucleocapsid, a tightly coiled structure formed primarily by the nucleoprotein wrapping around the RNA genome. Cryo-electron tomography of intact Marburg virions has shown that this nucleocapsid is left-handed in its helical twist. The inner helix is built by the conserved core region of NP, with the other nucleocapsid-associated proteins (VP24 and VP35) forming boomerang-shaped protrusions that extend outward.5PLOS Biology. Cryo-Electron Tomography of Marburg Virus Particles and Their Morphogenesis within Infected Cells This architecture is remarkably similar to what is seen in rhabdoviruses, pointing to an ancient evolutionary kinship between the two virus families.
Surrounding the nucleocapsid is the matrix layer, formed by the VP40 protein. VP40 exists as pairs (dimers) that link together into extended chains and then stack side by side to form a two-dimensional lattice beneath the viral membrane. This matrix layer is what gives the virus particle its elongated, filamentous shape and structural rigidity. Imaging of authentic Marburg virions shows that the VP40 chains run nearly perpendicular to the long axis of the filament, and the lattice geometry differs slightly between real virions and virus-like particles made in the lab, though the basic building block remains the VP40 dimer.6eLife. Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
The Surface Glycoprotein and Cell Entry
Marburg virus displays a single type of protein on its outer surface, the glycoprotein (GP), which is responsible for both attaching to and fusing with host cells.7PubMed Central. Structural basis for Marburg virus neutralization by a cross-reactive human antibody GP has a mucin-like region, a heavily sugar-coated stretch that shields much of the protein from immune recognition. Interestingly, this mucin-like region is not essential for the virus to get into cells, but Marburg’s GP appears more sensitive to small structural changes than Ebola’s, suggesting the two glycoproteins fold differently despite their shared function.8PubMed. Characterization of Marburg virus glycoprotein in viral entry
Once the virus binds to the cell surface, it is taken up into internal compartments called endosomes. Inside those compartments, host enzymes strip away the mucin-like region and other portions of GP, exposing a hidden binding site. That site then interacts with a protein called Niemann-Pick C1 (NPC1), which normally functions as a cholesterol transporter in the cell’s internal membranes. NPC1 is essential for filovirus entry: cells that lack it, including cells from patients with a rare genetic condition called Niemann-Pick type C1 disease, are resistant to both Marburg and Ebola infection while remaining susceptible to unrelated viruses.9PubMed Central. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 The interaction with NPC1 triggers the viral membrane to fuse with the endosomal membrane, dumping the nucleocapsid into the cell’s interior where replication begins.
Assembly and Budding
After the viral genome is copied and new proteins are made, Marburg virus assembles at the host cell’s outer membrane. VP40 dimers travel to the inner leaflet of that membrane, where they bind specific lipids and undergo a dramatic self-assembly process, linking together into the lattice that will become the matrix of the new virus particle.10Journal of Biological Chemistry. Lipid-specific oligomerization of the Marburg virus matrix protein VP40 is regulated by two distinct interfaces for virion assembly VP40 has two distinct interaction surfaces, one at its N-terminal domain and one at its C-terminal domain, and each requires a different membrane lipid to assemble properly. When this oligomerization is complete, VP40 drives the outward budding of the membrane, pinching off new filamentous particles that go on to infect neighboring cells.11PubMed Central. The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation
The Natural Reservoir
Egyptian fruit bats (Rousettus aegyptiacus) are the primary natural reservoir of Marburg virus. The evidence is strong: researchers have detected Marburg virus RNA in about 5% of wild-caught bats, found virus-specific antibodies in bat blood, and isolated genetically diverse strains of live virus from bat tissues.12PLoS Pathogens. Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats The bats appear to carry the virus without becoming seriously ill, a pattern seen with other bat-borne viruses. Experimental infections have confirmed that Egyptian fruit bats can shed Marburg virus orally, providing a plausible route by which virus-contaminated saliva, urine, or feces in bat roosts might reach humans.13PubMed Central. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus) Marburg viral RNA has been detected in Egyptian fruit bat populations across multiple African countries, including Uganda, the Democratic Republic of the Congo, and Zambia.14PubMed Central. Marburgvirus in Egyptian Fruit Bats, Zambia
Spillover Patterns and Seasonal Risk
Many documented Marburg outbreaks have begun with people entering bat habitats, particularly miners working in caves and underground gold mines in eastern Africa.15PubMed Central. Bat-Borne Pathogens and Public Health in Rural African Artisanal Gold Mines But about half of all known outbreaks have no clear link to cave exposure, which raises the question of how bats and humans cross paths in other settings. GPS tracking of bats from a known Marburg-infected colony revealed that the animals travel long distances at night to feed on cultivated fruit trees near homes, creating opportunities for contact that have nothing to do with caves.16PubMed Central. Micro‒Global Positioning Systems for Identifying Nightly Opportunities for Marburg Virus Spillover to Humans by Egyptian Rousette Bats
Spillover also follows a seasonal rhythm tied to bat breeding cycles. Field data show that juvenile bats are most likely to be infected with Marburg virus when they are roughly four and a half to seven and a half months old, a window that recurs twice a year in sync with the species’ biannual birthing seasons. Strikingly, about 85% of known human spillover events cluster during these same periods.17PLOS Pathogens. Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection This pattern held even when the analysis was expanded to include dozens of primary cases from a large outbreak in the Democratic Republic of the Congo. The implication is that the risk of catching Marburg from bats is not constant year-round but peaks predictably.
Human-to-Human Transmission
Once the virus enters the human population, it spreads through direct contact with the blood, vomit, or other bodily fluids of an infected person, especially during the later stages of illness when viral load is highest.18PubMed Central. Exploring the Epidemiology, Transmission Dynamics and Public Health Interventions of Marburg Viral Disease: A Scoping Review of Global Evidence Healthcare workers, caregivers, and family members preparing bodies for burial have been disproportionately affected in past outbreaks. Unlike airborne pathogens, Marburg virus does not spread efficiently through respiratory droplets under normal circumstances, which means that strict infection-control measures, barrier nursing, safe burial practices, and contact tracing, can effectively contain outbreaks when implemented early.
What the Virus Does Inside the Body
Marburg virus preferentially infects immune cells, particularly macrophages, monocytes, and dendritic cells, the very cells that are supposed to detect and coordinate the defense against invaders.19PubMed Central. Pathogenicity and virulence of Marburg virus By hijacking these sentinel cells, the virus simultaneously gains a vehicle for spreading throughout the body and cripples the host’s ability to mount an organized immune response. Infected macrophages carry the virus to the liver, spleen, and lymph nodes, seeding widespread infection before the immune system has had a chance to react.
A hallmark of Marburg’s pathogenesis is the massive, dysregulated release of inflammatory signaling molecules. Infected immune cells dump large quantities of cytokines and chemokines into the bloodstream, creating a feedback loop of escalating inflammation sometimes called a cytokine storm.20PubMed Central. The Role of Cytokines and Chemokines in Filovirus Infection This uncontrolled signaling damages blood vessel linings, increases vascular permeability, and contributes to the multi-organ failure that makes severe disease so lethal.
Immune Evasion by VP35
The virus does not merely outrun the immune system; it actively sabotages it. The VP35 protein suppresses the production of interferons, the signaling proteins that normally alert neighboring cells to a viral threat and activate antiviral defenses. VP35 blocks multiple steps in the interferon signaling cascade, including by directly binding double-stranded RNA, a molecular pattern that the immune system uses to detect viral replication.21PubMed Central. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins Marburg VP35 can coat the backbone of double-stranded RNA and also cap its exposed ends, making the RNA invisible to the cell’s virus-sensing machinery.22PLOS Pathogens. Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism Intriguingly, Marburg’s VP35 is roughly five times less potent at blocking interferon production than Ebola’s VP35 in laboratory assays, which may contribute to differences in how the two viruses behave clinically.
Endothelial Damage and Hemorrhage
The bleeding that gives the disease its “hemorrhagic fever” label stems from damage to the endothelial cells lining blood vessels. As the virus and the body’s own inflammatory response attack these cells, vessel walls become leaky, allowing fluid and blood to seep into surrounding tissues. The virus also disrupts the coagulation system, triggering widespread clotting in small blood vessels, a condition known as disseminated intravascular coagulation (DIC). DIC consumes the body’s supply of clotting factors, paradoxically leaving the patient unable to stop bleeding from other sites.23PubMed Central. Marburg Virus Disease: Pathophysiology, Diagnostic Challenges, and Global Health Preparedness Strategies Not every infected person develops overt hemorrhage, but when it occurs, it is a sign of rapidly deteriorating organ function and carries a grim prognosis.
Viral Persistence in Survivors
Surviving Marburg virus disease does not necessarily mean the virus is gone. Research in nonhuman primates has shown that Marburg virus can persist in immune-privileged sites, areas of the body where the immune system’s activity is naturally suppressed. The testes are a primary site of concern. In macaques that survived infection after antiviral treatment, active Marburg virus replication was found in the seminiferous tubules, the structures within the testes where sperm are produced. Researchers detected not just genomic RNA but also antigenomic RNA and viral glycoprotein, confirming that the virus was actively replicating rather than merely lingering as inert genetic material. Electron microscopy even revealed intact virus particles within those tissues.24Cell Host & Microbe. Testicular Marburg Virus Persistence and Associated Pathology in Nonhuman Primate Survivors This finding has direct public-health implications, as it raises the possibility of sexual transmission from survivors, a route documented for Ebola and now plausible for Marburg as well.25PubMed. Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors
Diagnosing Marburg Virus Disease
Early detection is critical for containing outbreaks but difficult in practice, because the initial symptoms of Marburg disease, fever, headache, muscle pain, are indistinguishable from malaria, typhoid, and many other tropical infections. Laboratory confirmation relies on detecting either the virus itself or the body’s immune response to it. In the first days of illness, when viral load is high, antigen-capture ELISA and RT-PCR are the most reliable tools. As the disease progresses and antibodies develop, IgM and IgG detection via ELISA or immunofluorescence becomes useful.26PubMed Central. The mortality, modes of infection, diagnostic tests, and treatments of Marburg virus disease: A systematic review
A major challenge is that most outbreaks occur in remote areas with limited laboratory infrastructure. To address this, researchers have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for Marburg virus that can detect viral RNA in about 40 minutes without the sophisticated thermal cycling equipment that standard PCR requires. In field testing against samples from the 2005 Angola outbreak, the assay showed results that could be read by eye, making it a practical option for frontline diagnostics.27PubMed Central. Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method
Experimental Treatments and Vaccines
No approved antiviral drug or vaccine exists specifically for Marburg virus disease, but the pipeline has become considerably more active. On the therapeutic side, a combination of the antiviral remdesivir and a monoclonal antibody called MR186-YTE protected 80% of macaques from lethal Marburg infection when treatment began after symptoms appeared.28Nature Communications. Combination therapy protects macaques against advanced Marburg virus disease Another monoclonal antibody, MR191-N, provided up to 100% survival in macaques infected with either the Marburg or Ravn strains of the virus when administered up to five days after exposure.29PubMed Central. Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody These results are promising but remain in animal models; translating them to human outbreaks is a logistical and ethical challenge, since randomized trials during fast-moving epidemics are notoriously hard to conduct.
Vaccine development has advanced further. A chimpanzee adenovirus-vectored vaccine called cAd3-Marburg completed a first-in-human Phase 1 trial showing it was safe, well tolerated, and immunogenic. About 95% of participants developed glycoprotein-specific antibodies within four weeks of a single dose, and those antibodies remained elevated at 48 weeks. Side effects were mild: injection-site soreness, fatigue, and headache were the most common complaints.30The Lancet. Safety and immunogenicity of a chimpanzee adenovirus-vectored Marburg virus vaccine: a first-in-human, phase 1, open-label, dose-escalation trial Global health authorities have identified cAd3-Marburg as one of the most promising candidates, drawing on the rapid-development models established during the COVID-19 pandemic to accelerate further testing.31PubMed. Marburg virus reaches Rwanda: how close are we to a vaccine solution?
Long-Term Health in Survivors
What happens to people who survive Marburg virus disease has received far less attention than the acute illness, partly because the total number of survivors worldwide is small. A study that assessed nine survivors roughly 13 years after their infection found lasting physiological changes, including elevated blood pressure, higher body mass index, and disruptions in markers of liver and kidney function compared with matched controls. Blood work revealed persistent changes in red blood cell production, with elevated reticulocyte counts despite normal hemoglobin levels, suggesting the bone marrow was still compensating for some ongoing process. Two chronic symptoms, headache and visual disturbance, persisted beyond the acute phase in some survivors.32PubMed Central. Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity
Perhaps the most surprising finding was the psychological profile. None of the nine survivors met criteria for clinically significant anxiety or depression on standardized screening tools, a sharp contrast with survivors of Ebola, who frequently report lasting psychological distress. The reasons for this difference are not clear. It could reflect the small sample size, cultural factors, the passage of time, or genuine biological differences in how the two diseases affect the central nervous system. With so few cases to study, the picture of long-term Marburg survivorship remains incomplete, but the emerging data suggest that the body’s scars may be more metabolic and cardiovascular than psychiatric.